Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tecnonuclear is an Argentine nuclear medicine specialist and manufacturer of radiopharmaceuticals, cold kits, and Technetium-99m generators. Founded in 1992 and based in Buenos Aires, the company produces a wide range of diagnostic and therapeutic products for SPECT, PET, and magnetic resonance imaging (MRI). Its portfolio includes cold kits that act as vectors for delivering Technetium-99m to specific biological targets, as well as therapeutic radioisotopes like Iodine-131. In January 2022, Tecnonuclear was acquired by the German medical technology company Eckert & Ziegler, which has integrated it to expand its global SPECT and nuclear medicine footprint.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tecnonuclear.